The authors showed that three months after bone marrow transplantation, an increase in the BCR/ABL transcript was observed in this group of 15 patients, which correlated with a high 3-year cumulative incidence of relapse and worse leukemia-free survival and overall survival (30). This evidence concerns the gene BCR and leukemia.